Capillary Electrophoresis Market - By Product, By Type, By Application, By End Use - Global Forecast 2025 - 2034

Capillary Electrophoresis Market Size

The global capillary electrophoresis market was estimated at USD 367.2 million in 2024. The market is expected to grow from 386.3 million in 2025 to 633.1 million in 2034, at a CAGR of 5.6%. Capillary electrophoresis is a laboratory technique that separates small particles, such as molecules or ions according to their size and charge.
 

In this process, the particles move through thin tube when an electric current is applied and they move at different speeds, depending on their size and charge. This method is helpful for studying molecules such as DNA, protein, and other small molecules.
 

The capillary electrophoresis market is experiencing significant growth, stimulated by the growing incidence of infectious disease such as HIV, TB, Malaria, among others. According to World Health Organization (WHO) by the end of 2022, there were an estimated 39 million people living with HIV globally, of which 37.5 million were aged 15 and 1.5 million were children aged under 15 years. This growing burden of infectious disease has led to a heightened demand for precise and effective diagnostic techniques such as capillary electrophoresis which provides high resolution separation and analysis, making it crucial in the detection and understanding of infectious pathogens. The rising demand for capillary electrophoresis positions it as a crucial instrument in both clinical and research context.
 

In addition to the growing prevalence of disease, the market is also being influenced by the increasing focus on precision medicine and personalized treatment. With healthcare continues to shift towards more individualized care, the demand for technologies that can provide accurate, high-resolution data is intensifying. This technology is important for identifying genetic markers and studying pathogens, which are crucial for developing personalized treatment strategies. Therefore, capillary electrophoresis is enhancing the effectiveness of targeted therapies, further solidifying its role in the evolving healthcare landscape and stimulating growth in the market.
 

Capillary Electrophoresis Market Trends

• The global burden of non-communicable diseases (NCDs) continues to be a significant public health challenge with increasing morbidity and mortality worldwide. For instance, as per the data from the World Health Organization (WHO), NCDs were responsible for at least 43 million deaths in 2021, which is equivalent to 75% of non-pandemic related deaths globally. These diseases include cancer, cardiovascular disease, chronic respiratory disease, diabetes which have become the leading cause of death and disability around the world.
   
• Among these diseases, ischemic heart disease topped the list, causing 9 million deaths in 2021, while stroke was the second most common cause responsible for 7 million deaths, according to the data from Statista.
   
• Thus, technologies such as capillary electrophoresis are gaining prominence for their ability to deliver high-resolution separation and analysis of complex biomolecules associated with these diseases. The role of capillary electrophoresis in studying biomarkers has made it a vital tool in the early detection and personalized treatment of NCDs. This has catalysed its adoption within clinical and research settings, accelerating the demand for capillary electrophoresis instruments to support more efficient, targeted healthcare approaches.
   

Capillary Electrophoresis Market Analysis

Based on the product, the market is segmented into instruments, consumables, and software. The market was estimated at USD 349.3 million in 2023. The consumables segment held revenue of USD 216.5 million in 2024, and the segment is poised for significant growth at a CAGR of 5.4% during the forecast period.
 

• Consumables such as capillaries and electrophoresis reagents, which is estimated to reach USD 4.2 billion in 2032, are crucial for daily capillary electrophoresis operations. These essential components are vital for the separation process, and the quality and type of capillaries used directly impact the performance and accuracy of the technique. The constant demand for innovation and high-quality capillaries is one of the accelerating factors for the growth of the consumables segment in the market.
   
• Reagents, including buffer and detection chemicals are also key consumables in capillary electrophoresis. These reagents are used to prepare samples, maintain system, and give high precision analysis during electrophoresis process. Their quality and effectiveness contribute significantly to the overall performance of the capillary electrophoresis technique.
   
• The continues advancement in this segment resulted in the adoption of capillary electrophoresis technique in analyzing peptides, proteins, and small molecules, helping in drug development and quality control processes.
   
• In 2021 the National Library of Medicine highlighted the growing use of capillary electrophoresis for determining active compounds in medicinal plants and pharmaceutical formulations. With the increase in demand for high precision analytical technology such as the capillary electrophoresis, the consumable segment is anticipated to grow further supporting advancement in research and healthcare.

Based on the type, capillary electrophoresis market is segmented into capillary zone electrophoresis (CZE), micellar electrokinetic capillary chromatography (MEKC), capillary electrochromatography (CEC), capillary isoelectric focusing (CIEF), capillary isotachophoresis (CITP), and capillary gel electrophoresis (CGE). The capillary gel electrophoresis segment dominated the market with a market share of 45.7% in 2024.
 

• Capillary gel electrophoresis (CGE) which is a powerful procedure helps to isolate large biomolecules such as proteins, DNA, and RNA with precision. This device can be used in different areas, including genetic testing, sequencing, and protein research. CGE is different from other techniques as its capacity to efficiently sort large particles makes it useful and is broadly utilized in these areas.
   
• One of CGE's key roles is in genetic testing and sequencing, where it allows scientists to closely examine DNA and other genetic material. This is essential for genetic analysis and also for spotting genetic mutations. CGE is also critical in sequencing methods such as Sanger sequencing and next-generation sequencing, where separating DNA fragments by size is key to getting accurate results in genetic analysis.
   
• Additionally, according to PubMed, CGE has been utilized for over two decades in protein separation. Continuous advancement in CGE technology have made it a routine method for analysing protein-based pharmaceuticals and quality control tests. The technology is evolving, so as the CEG’s sensitivity, leading to its broader adoption not only in academic and clinical research but also in industries such as biotechnology, wherein the analysis of large biomolecules is essential.
   

Based on the application, capillary electrophoresis market is segmented into nucleic acid analysis, protein analysis, genomic DNA, plasmid DNA, fragment analysis, RNA/mRNA analysis, and other applications. The nucleic acid analysis segment dominated the market with a market share of 28.2% in 2024
 

• Nucleic acid analysis plays a crucial role in genomic medicine. It includes a variety of application such as disease diagnosis, research, and genetic testing. For instance, genomic testing has become standard practice in diagnosing disease such as cancer, rare genetic disorders, among others.
   
• For instance, in 2022, approximately 20 million new cancer cases were diagnosed worldwide, as reported by American Cancer Society, with projections suggesting this number could rise to 35 million by 2050. Thus, as the prevalence of these diseases increase so does the need for effective genomic testing tools such as capillary electrophoresis for the detection of the biomarkers associated with this disease.
   
• Furthermore, the rise in next generation sequencing has further emphasized the need for reliable nucleic acid analysis tools. With genomic medicine evolving rapidly, the nucleic acid analysis segment is expected to continue dominating the market.
   

Based on the end use, capillary electrophoresis market is segmented into pharmaceutical and biotechnology companies, academic and research organizations, clinical laboratories, and other end users. The academic and research organizations segment held revenue of USD 184.7 million in 2024, and the segment is poised for significant growth at a CAGR of 5.7% during the forecast period.
 

• High demand for capillary electrophoresis in academic and research organizations is primarily accelerated by the continuous investment, advancements, and scientific discoveries particularly in genomic research. According to a report from the National Science Foundation (NSF) 2023, U.S. universities and research institutes spent approximately USD 97.8 billion in 2022, an increase of USD 8 billion from 2021 spent on research and development highlighting the importance of academic organizations in adopting technological advanced research tools such capillary electrophoresis for various research activities. Moreover, the National Institute of Health invest most of its USD 48 million budget in medical research annually.
   
• Capillary electrophoresis is crucial in academic and medical research for precise analysis of biomolecules such as protein and nucleic acids. Its ability to provide high resolution and sensitive separation of the molecules makes it an important tool for researchers.
   
• Additionally, the growth of the genomic and proteomics field has further increased the use of capillary electrophoresis in academic and research settings with increase in investments in this field.
   

• The U.S. market is seeing significant growth, stimulated by the increasing demand for disease diagnosis, particularly for cancer detection. This technique is crucial for identifying gene polymorphism associate with cancer prognosis and therapy, making it a valuable tool in personalised medicine.
   
• Researchers at the U.S. Department of Energy’s Ames Laboratory have introduced a method known as dynamic multiple equilibrium gradients (DMEG), which significantly enhances the resolutions and accuracy of capillary electrophoresis. DMEG has proven effective in detecting biomarkers such as estrogen-derived conjugates and DNA adducts, in human fluid samples. These biomarkers can potentially indicate early-stage breast and prostate cancer, which could lead to earlier diagnosis and more effective treatment plans.
   
• Such technological advancements in capillary electrophoresis are paving the way for improved patient outcomes and the development of personalized treatment strategies further driving the market growth in the U.S.
   

Europe: The capillary electrophoresis market in the UK is projected to grow significantly from 2025 to 2034.
 

• UK is leader in biomedical research and drug development which relies highly on techniques such as capillary electrophoresis for analysis of biomolecules.
   
• The UK’s National Health Service has been actively investing in advance diagnostic technologies. For instance, the 2024 Spring Budget included an NHS productivity plan backed by GBP 3.4 billion to invest in technological and digital transformation, encompassing the upgrading of diagnostic equipment and the integration of artificial intelligence to enhance diagnostic accuracy and efficiency.
   
• Thus, such investment is anticipated to improve the healthcare delivery and stimulate the adoption of capillary electrophoresis in clinical laboratories for disease diagnostic and molecular analysis.
   

Asia Pacific: The capillary electrophoresis market in the Japan is projected to grow significantly from 2025 to 2034.
 

• Japan’s progressed healthcare framework and its leading role in scientific research are key components fuelling the developing demand for precise instruments such as capillary electrophoresis. The country’s commitment towards progressing healthcare makes it easier to receive and implement innovative technologies.
   
• Additionally, Japan’s strong focus on medical and pharmaceutical research is stimulating the use of capillary electrophoresis across various fields, from drug development to molecular diagnostics. This push for innovation is expanding the application of capillary electrophoresis in both clinical and research environments, helping it establishes a bigger presence in the market.
   

Middle East and Africa: The Saudi Arabia capillary electrophoresis market is projected to grow significantly from 2025 to 2034.
 

• The country’s healthcare industry is experiencing rapid growth due to rising incidences of chronic diseases such as cancer, diabetes, etc. where capillary electrophoresis plays a major role in disease monitoring and drug development.
   
• Thus, there is a growing demand for advanced clinical tools in Saudi Arabia such as capillary electrophoresis, particularly for genetic testing, cancer detection.
   

Capillary Electrophoresis Market Share

The market is competitive with a mix of established companies and emerging players offering innovative technologies and solutions. Leading 3 firms in the market such as Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories and Merck, together account for approximately 35% of the total market share. These companies focus on continuous advancement in capillary electrophoresis technology, including improvements in system resolution, speed and automation to cater to the growing demand from research labs, and academic institutions and the increasing applications of capillary electrophoresis in proteomics, genomics and pharmaceutical industries are contributing to the increasing market share for these industry leaders.
 

Capillary Electrophoresis Market Companies

Some of the eminent market participants operating in the capillary electrophoresis industry include:

• Agilent Technologies
• Bio-Rad Laboratories
• Bio-Techne
• Danaher Corporation
• Helena Laboratories Corporation
• Lumex Instruments
• Merck
• Prince Technologies
• QIAGEN
• Thermo Fisher Scientific
   
• Bio-Rad Laboratories is a well-established players known for its leading solutions. The company has an extensive portfolio of various applications. The company is heavily investing in research and development to facilitate advancement in technologies. For instance, in 2024 the company has invested 295.9 million in research and development as per the company’s annual report.
   
• Thermo Fisher Scientific is one of the leading providers of laboratory instruments. The company offers a wide range of products and services and it has presence over 50 countries worldwide.
   

Capillary Electrophoresis Industry News

• In January 2024, Agilent Technologies introduced the ProteoAnalyzer system, an advanced capillary electrophoresis platform designed to streamline and enhance the analysis of complex protein mixtures. This innovative system improves the efficiency and accuracy of protein analysis, providing researchers with faster and more reliable results. The launch of the ProteoAnalyzer strengthened Agilent’s position in the market, further solidified its leadership in scientific instrumentation.
   
• In May 2022, QIAGEN launched QIAxcel, a highly sensitive capillary electrophoresis instrument designed to meet the increasing demand for efficient and precise biomolecule analysis. This innovative instrument simplifies the analysis process, offering faster results without compromising the quality of data. The launch strengthened QIAGEN’s competitive position in the market.
   

The capillary electrophoresis market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2025 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Instruments
  • Automatic capillary electrophoresis systems
  • Semi-automatic capillary electrophoresis systems
• Consumables
• Software

Market, By Type

• Capillary zone electrophoresis (CZE)
• Micellar electrokinetic capillary chromatography (MEKC)
• Capillary electrochromatography (CEC)
• Capillary isoelectric focusing (CIEF)
• Capillary isotachophoresis (CITP)
• Capillary gel electrophoresis (CGE)

Market, By Application

• Nucleic acid analysis
• Protein analysis
• Genomic DNA
• Plasmid DNA
• Fragment analysis
• RNA/mRNA analysis
• Other applications

Market, By End Use

• Pharmaceutical and biotechnology companies
• Academic and research organizations
• Clinical laboratories
• Other end use

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands 
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE